Cargando…

Immunological predictors of CD4(+ )T cell decline in antiretroviral treatment interruptions

BACKGROUND: The common response to stopping anti-HIV treatment is an increase of HIV-RNA load and decrease in CD4(+), but not all the patients have similar responses to this therapeutic strategy. The aim was to identify predictive markers of CD4(+ )cell count declines to < 350/μL in CD4-guided an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seoane, Elena, Resino, Salvador, Moreno, Santiago, de Quiros, Juan Carlos Lopez Bernaldo, Moreno, Ana, Rubio, Rafael, Gonzalez-García, Juan, Arribas, José Ramón, Pulido, Federico, Muñoz-Fernández, Ma Ángeles
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291054/ https://www.ncbi.nlm.nih.gov/pubmed/18302775 http://dx.doi.org/10.1186/1471-2334-8-20

Ejemplares similares

Frailty, markers of immune activation and oxidative stress in HIV infected elderly
por: Álvarez, Susana, et al.
Publicado: (2020)

Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy
por: Resino, Salvador, et al.
Publicado: (2006)

Predictors of SIV recrudescence following antiretroviral treatment interruption
por: Pinkevych, Mykola, et al.
Publicado: (2019)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
por: Resino, Salvador, et al.
Publicado: (2006)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2006)

Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique
por: Palladino, Claudia, et al.
Publicado: (2013)

Predictors of antiretroviral therapy interruptions and factors influencing return to care at the Nkolndongo Health District, Cameroon
por: Nsoh, Marius, et al.
Publicado: (2021)

Maternal CD4+ Cell Count Decline after Interruption of Antiretroviral Prophylaxis for the Prevention of Mother-to-Child Transmission of HIV
por: Ekouevi, Didier, et al.
Publicado: (2012)

Environmental Factors Related to Pulmonary Tuberculosis in HIV-Infected Patients in the Combined Antiretroviral Therapy (cART) Era
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2016)

Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2017)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Trends in pulmonary embolism in patients infected with HIV during the combination antiretroviral therapy era in Spain: A nationwide population-based study
por: Alvaro-Meca, Alejandro, et al.
Publicado: (2018)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
por: López-Huertas, María Rosa, et al.
Publicado: (2020)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study
por: Martínez‐Sanz, Javier, et al.
Publicado: (2021)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

IL7RA rs6897932 Polymorphism Is Associated with Better CD4(+) T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2019)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
por: Sungkanuparph, Somnuek, et al.
Publicado: (2007)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Feasibility and application of a retronasal aroma-trapping device to study in vivo aroma release during the consumption of model wine-derived beverages
por: Muñoz-González, Carolina, et al.
Publicado: (2014)

Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected
por: Gutiérrez, Carolina, et al.
Publicado: (2011)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
por: Bonney, Evelyn Y., et al.
Publicado: (2021)

Predictors of Clinical and Immunological Failure Among Patients on First-Line Antiretroviral Therapy (ART) in Southwest Ethiopia
por: Asefa, Adane, et al.
Publicado: (2019)

The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection
por: Klein, Nigel, et al.
Publicado: (2013)

Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study
por: Machado, Carmen, et al.
Publicado: (2012)

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
por: Berenguer, Juan, et al.
Publicado: (2021)

Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997–2008)
por: Álvaro-Meca, Alejandro, et al.
Publicado: (2013)

National Temporal Trend Analysis of Infective Endocarditis among Patients Infected with HIV in Spain (1997–2014): A Retrospective Study
por: Muñoz-Moreno, Maria Fe, et al.
Publicado: (2019)

Gender-based vulnerability in women who inject drugs in a harm reduction setting
por: Valencia, Jorge, et al.
Publicado: (2020)

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
por: Pérez-Valero, Ignacio, et al.
Publicado: (2013)

DBP rs7041 and DHCR7 rs3829251 are Linked to CD4(+) Recovery in HIV Patients on Antiretroviral Therapy
por: Resino, Salvador, et al.
Publicado: (2022)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
por: Mamo, Ayele, et al.
Publicado: (2022)

Unplanned antiretroviral treatment interruptions in southern Africa: how should we be managing these?
por: Veenstra, Nina, et al.
Publicado: (2010)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study
por: Gomez-Moreno, Ana Zaida, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i0di7i6uce06kmohdbjegv95pi